Prevest Denpro Ltd

- The transcript does not mention any current or future fundraising plans through debt or equity. - The discussion primarily focuses on business growth, revenue, margin guidance, capacity expansion, and market penetration. - Capex plans include Rs. 2.9 Crores for renovation, Rs. 8 Crores for R&D, and Rs. 8 Crores for expansion and modernization, funded through internal accruals or existing resources (not explicitly stated). - No details about raising funds via debt or equity were provided during this call.

- Proposed capex for the financial year includes: - Rs. 2.9 Crores for renovation of existing plant and machinery. - Rs. 8 Crores for R&D facilities. - Rs. 8 Crores for expansion projects and modernization. - R&D center expected to be operational by Q2 FY2023. - New facilities for manufacturing disinfectant oral hygiene products, oral care products, and biomaterials are under advanced implementation, projected to be fully operational by Q3 FY2023, subject to regulatory approvals. - Modernization efforts ongoing with new high-speed machines installed, streamlining production and increasing capacity to cater to market demand over the next five years. - Total expanded capex made so far amounts to Rs. 11.04 Crores. - Additional modernization expenditure of around Rs. 1 Crore already spent, with another Rs. 1 Crore planned for upcoming months. Overall, key investments focus on capacity expansion, product innovation, and modernization to support growth.

- The company expects to maintain the same topline growth and bottomline. - Business is growing phenomenally at 30% to 40% year-on-year. - Revenue for the current financial year is projected to cross Rs. 50 Crores. - Growth drivers include high-quality production, good pricing, and marketing strategies. - New product introductions from the operational R&D center will further boost growth. - Expansion into international markets like the US, Brazil, Russia, and Saudi Arabia is a major focus. - Export business is set to improve with new registrations and US FDA approvals. - Increased digital marketing activities aim to connect with more dentists globally. - Modernization and capacity expansion of manufacturing facilities support higher production volumes. - The company is optimistic about sustained growth fueled by high-value specialized dental products.

- Prevest DenPro aims to maintain strong topline growth and sustain the high EBITDA margin of around 40%, driven by specialized, value-added dental products with good pricing power. - Revenue for FY2023 is expected to exceed Rs. 50 Crores with sustained profitability. - The company plans robust international expansion, targeting entry into high-potential markets like the US, Brazil, and Russia, complementing existing exports to 85 countries. - New capacity expansions and modernization are underway to meet growing demand efficiently. - Operating margins are considered sustainable and expected to improve with market diversification, including entry into markets with better margin profiles, like the US. - R&D investments and launch of new product lines (disinfectant, oral hygiene, biomaterials) are expected to fuel growth. - Quarterly accounting changes in employee costs may normalize expense recognition, improving clarity in future earnings. - Overall, management is confident of continued double-digit growth in earnings and profits supported by strong fundamentals and business durability.

- The current order book of Prevest DenPro Limited is described as very comfortable with sufficient orders at present. - The company is confident about continuing its growth without any disruption in the order inflow. - There is no indication of lumpiness or delays in advanced payments from European countries despite economic instability, as payments are received on 100% advance basis. - Saudi Arabian market is growing well with very good quantity of product orders, and the company expects much better business growth there in the coming times. - The company is proactively expanding in international markets like US, Brazil, and Russia, and is engaging with potential buyers, suggesting a growing order pipeline. - Overall, the business prospects and order inflow are stable and strong, supporting the company’s growth trajectory.